🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a multinational, randomised, double-blind, placebo-controlled, par...
Status
Completed
Location
Multiple Locations
Start Date
2009-04
Trial ID
NCT01820559
Treatments Being Tested
This is an 18-week, double-blind, multicenter study with gradual conversion...
Status
Completed
Location
University of Arizona Health Sciences Center
Start Date
2010-06
Trial ID
NCT01091662
Treatments Being Tested
This is an open Label study to investigate the safety and efficacy of eslic...
Status
Completed
Location
Universitätsklinik für Neurologie; Arbeitsgruppe Epileptologie
Start Date
2010-04
Trial ID
NCT01422720
Treatments Being Tested
The primary objective of this study is to assess the efficacy of Eslicarbaz...
Status
Terminated
Location
Synexus ClinPharm GmbH
Start Date
2010-09
Trial ID
NCT01124097
Treatments Being Tested
The primary objective of the study is to assess the efficacy of eslicarbaze...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00980746
Treatments Being Tested
This is a long term, open-label, safety extension study in subjects with pa...
Status
Completed
Location
Neurology Clinic, P.C.
Start Date
2009-08
Trial ID
NCT00910247
Treatments Being Tested
This is a Phase III, multinational, open-label, non-controlled study with s...
Status
Completed
Location
Multiple Locations
Start Date
2016-03-01
Trial ID
NCT02484001
Treatments Being Tested
This was a Non-interventional Prospective Study. Centres enrolled adult pat...
Status
Completed
Location
Multiple Locations
Start Date
2012-04
Trial ID
NCT01830400
Treatments Being Tested
The purpose of this study is to determine whether Eslicarbazepine acetate (...
Status
Completed
Location
University of South Alabama Department of Neurology
Start Date
2008-12-02
Trial ID
NCT00988429
Treatments Being Tested
The primary objective of this study is to assess the efficacy of Eslicarbaz...
Status
Terminated
Location
BIAL - Portela & Cª, S.A.
Start Date
2010-11
Trial ID
NCT01129960
Treatments Being Tested